AIC
ZYNE

Archer Investment Corporation’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Archer Investment Corporation’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-200
Closed -$1K – 650
2019
Q4 		$1K Buy
+200
New +$1.37K ﹤0.01% 597

Other funds holding ZYNE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Archer Investment Corporation's ZYNE Position: Q1 2020 in Review

Archer Investment Corporation sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q1 2020, closing a stake of 200 shares — an estimated $1K sold.

Archer Investment Corporation first reported a position in ZYNE in Q4 2019 and held it in 1 quarter. The position peaked at $1K in Q4 2019. 77 funds tracked by Wall St. Rank hold ZYNE as of Q1 2020.

  • Archer Investment Corporation reported no remaining Zynerba Pharmaceuticals, Inc position as of Q1 2020 after selling out during the quarter.
  • Archer Investment Corporation sold 200 Zynerba Pharmaceuticals, Inc shares in Q1 2020, an estimated $1K.
  • Archer Investment Corporation first reported a position in Zynerba Pharmaceuticals, Inc in Q4 2019 and held it in 1 quarter.
  • Archer Investment Corporation's Zynerba Pharmaceuticals, Inc position peaked at $1K in Q4 2019.
  • 77 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q1 2020.

Based on Archer Investment Corporation's 13F filing for Q1 2020, filed 7 May 2020.